Search Results - "Salvioni, E."

Higgs low-energy theorem (and its corrections) in composite models by Gillioz, M., Gröber, R., Grojean, C., Mühlleitner, M., Salvioni, E.

“…A bstract The Higgs low-energy theorem gives a simple and elegant way to estimate the couplings of the Higgs boson to massless gluons and photons induced by…”
Get full text

Very boosted Higgs in gluon fusion by Grojean, C., Salvioni, E., Schlaffer, M., Weiler, A.

“…A bstract The Higgs production and decay rates offer a new way to probe new physics beyond the Standard Model. While dynamics aiming at alleviating the…”
Get full text

Taming the off-shell Higgs boson by Azatov, A., Grojean, C., Paul, A., Salvioni, E.

“…We study the off-shell Higgs data in the process pp → h (*) → Z (*) Z (*) → 4 l , to constrain deviations of the Higgs couplings. We point out that this…”
Get full text

Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] by Paolillo, S., Salvioni, E., Perrone Filardi, P., Bonomi, A., Sinagra, G., Gentile, P., Gargiulo, P., Scoccia, A., Cosentino, N., Gugliandolo, P., Badagliacca, R., Lagioia, R., Correale, M., Frigerio, M., Perna, E., Piepoli, M., Re, F., Raimondo, R., Minà, C., Clemenza, F., Bussotti, M., Limongelli, G., Gravino, R., Passantino, A., Magrì, D., Parati, G., Caravita, S., Scardovi, A.B., Arcari, L., Vignati, C., Mapelli, M., Cattadori, G., Cavaliere, C., Corrà, U., Agostoni, P.

Get full text

Beta-blockers effects according to sex: does selectivity and dose equally matter? by Salvioni, E, Paolillo, S, Galotta, A, Mapelli, M, Mattavelli, I, Basile, C, Vignati, C, Moscucci, F, Piepoli, M, Agostoni, P

“…Abstract Background β-blockers are one of the four recommended disease-modifying classes of drugs for the treatment of heart failure with reduced ejection…”
Get full text

Prognostic evaluation of heart failure in women: insight from the MECKI score database by Salvioni, E, Moscucci, F, Bonomi, A, Mapelli, M, Paolillo, S, Corra, U, Vignati, C, Mattavelli, I, Magri, D, Sciomer, S, Piepoli, M, Agostoni, P

“…Abstract Background Heart failure (HF) in women often assumes extremely peculiar characteristics. The risk stratification and prognostic evaluation of HF in…”
Get full text

Cardiac reverse remodelling by 2D and 3D echocardiography in heart failure patients treated with sacubitril/valsartan: a prospective study by Mantegazza, V, Volpato, V, Mapelli, M, Sassi, V, Salvioni, E, Mattavelli, I, Tamborini, G, Agostoni, P, Pepi, M

“…Abstract Background Left ventricular (LV) reverse remodelling induced by sacubitril/valsartan (S/V) has been shown in heart failure patients with reduced…”
Get full text

PROGNOSTIC PERFORMANCE OF MECKI SCORE IN HEART FAILURE PATIENTS WITH NON–VALVULAR ATRIAL FIBRILLATION TREATED WITH EDOXABAN by Mapelli, M, Mattavelli, I, Salvioni, E, Bonomi, A, Capra, N, Vignati, C, Cattadori, G, Agostoni, P

“…Abstract Background Risk stratification in heart failure (HF) is crucial for clinical and therapeutic management. The Metabolic Exercise test data combined…”
Get full text

Dysregulation of iron metabolism-linked genes at myocardial tissue and cell levels in dilated cardiomyopathy by Massaiu, I., Campodonico, J., Mapelli, M., Salvioni, E., Valerio, V., Moschetta, D., Myasoedova, V., Cappellini, M., Pompilio, G., Agostoni, P., Poggio, P.

Get full text

Would be the minute ventilation variability an alternative to the dichotomous diagnosis of exercise oscillatory ventilation? by Karsten, M, Ribeiro, GS, Deresz, LF, Salvioni, E, Silveira, LS, Hansen, D, Agostoni, P

“…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): CAPES and FAPERGS. Background…”
Get full text

Brain natriuretic peptide levels are associated with cycle length average and are different between Ben-Dov and Corra exercise oscillatory ventilation definitions in heart failure patients by Ribeiro, GS, Deresz, LF, Salvioni, E, Silveira, LS, Hansen, D, Agostoni, P, Karsten, M

“…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): CAPES e FAPERGS. Background The…”
Get full text

DIFFERENT FATES AND ROUTES OF CHRONIC HEART FAILURE, AN ARTIFICIAL INTELLIGENT BASED ANALYSIS OF THE MECKI SCORE DATASET by Chiesa, M, Salvioni, E, Emdin, M, Piepoli, M, Sinagra, G, Sanni, M, Mapelli, M, Limongelli, G, Parati, G, Agostoni, P

“…Abstract Background Individual prognostic assessment and disease evolution pathways in chronic heart failure (HF) are unmet needs. The application of…”
Get full text

Dysregulation of iron metabolism-linked genes at myocardial tissue and cell levels in dilated cardiomyopathy by Massaiu, I, Campodonico, J, Mapelli, M, Salvioni, E, Valerio, V, Moschetta, D, Myasoedova, V, Cappellini, M, Pompilio, G, Poggio, P, Agostoni, P

“…Abstract Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): Fondazione Gigi & Pupa Ferrari ONLUS Italian Ministry…”
Get full text

Different kinetics of NT-proBNP and sST2 highlight different therapeutic pathways of sacubitril/valsartan by Mattavelli, I, Mapelli, M, Salvioni, E, Bonomi, A, Palermo, P, Banfi, C, Paolillo, S, Biondi, M L, Agostoni, P

“…Abstract Funding Acknowledgements Type of funding sources: None. Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) and soluble interleukin 1…”
Get full text

P309 DIFFERENT KINETICS OF NT–PROBNP AND SST2 HIGHLIGHT DIFFERENT THERAPEUTIC PATHWAYS OF SACUBITRIL/VALSARTAN by Mapelli, M, Mattavelli, I, Salvioni, E, Bonomi, A, Palermo, P, Banfi, C, Paolillo, S, Biondi, M, Agostoni, P

“…Abstract Background N–terminal pro–B–type natriuretic peptide (NT–proBNP) and soluble interleukin 1 receptor–like 1 ST2 (sST2) are biomarkers used to grade…”
Get full text

Cardiovascular death risk in mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test by Gallo, G, Piepoli, M, Corra', U, Salvioni, E, Perrone Filardi, P, Metra, M, Limongelli, G, Senni, M, Parati, G, Cicoira, M.A, Sciomer, S, Sinagra, G, Volpe, M.A, Agostoni, P, Magri', D

“…Abstract Background The pivotal role of cardiopulmonary exercise testing (CPET) in the assessment of functional capacity and prognosis of patients with heart…”
Get full text

Sacubitril/valsartan improves exercise performance in patients with heart failure: a dose-dependent effect by Mattavelli, I, Mapelli, M, Salvioni, E, Paolillo, S, De Martino, F, Vignati, C, Magri', D, Mantegazza, V, Tamborini, G, Agostoni, P

“…Abstract Funding Acknowledgements Type of funding sources: None. Background Sacubitril/Valsartan therapy has become a cornerstone of heart failure with reduced…”
Get full text

P251 PERIODIC BREATHING (EOV) ON CARDIORESPIRATORY STRESS TESTING: ARE THERE PROGNOSTIC DIFFERENCES BETWEEN PATIENTS WITH PERIODIC BREATHING THAT PERSISTS THROUGHOUT THE TEST AND PATIENTS TO WHOM IT DISAPPEARS? by Palermo, P, Apostolo, A, Contini, M, Mapelli, M, Alessandra, M, De Martino, F, Salvioni, E, Agostoni, P

“…Abstract Introduction Oscillatory exercise ventilation (EOV) is frequently seen in patients with severe heart failure (HF) and has a ne:gative prognostic value…”
Get full text

P216 DAPAGLIFLOZIN USE IN HFREF PATIENTS: A SINGLE CENTRE COMPARISON BETWEEN REAL–LIFE AND DAPA–HF DATA by Mapelli, M, Capovilla, T, Mattavelli, I, Salvioni, E, Marongiu, A, Maranzano, G, Paganin, C, Vignati, C, Palermo, P, Sinagra, G, Agostoni, P

“…Abstract Background Practice guidelines recommend Sodium–glucose co–transporter–2 inhibitors (SGLT2–i) for patients with heart failure with reduced ejection…”
Get full text

P286 IMPACT OF PERSONAL PROTECTIVE MASKS ON CARDIORESPIRATORY VARIABLES IN HEALTHY SUBJECTS AND PATIENTS WITH HEART FAILURE: AN INTERIM ANALYSIS by Mapelli, M, Bidoglio, J, Salvioni, E, Mattavelli, I, Gugliandolo, P, De Martino, F, Vignati, C, Campodonico, J, Palermo, P, Agostoni, P

“…Abstract Background protective masks are a powerful mean to contain COVID–19. However, a general feeling that masks alter the normal dynamics of breathing may…”
Get full text